Novo Nordisk to acquire obesity drug maker Inversago Pharma for up to $1 billionInversago's drugs use a different approach than most treatments in the obesity and diabetes space.[Collection]

Inversago's drugs use a different approach than most treatments in the obesity and diabetes space.https://www.cnbc.com/2023/08/10/novo-nordisk-to-acquire-inversago-pharma-canadian-obesity-drug-maker-.html